Dec 18
|
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
|
Dec 7
|
Why Is Iovance Biotherapeutics (IOVA) Up 53% Since Last Earnings Report?
|
Dec 7
|
Recent uptick might appease Moderna, Inc. (NASDAQ:MRNA) institutional owners after losing 55% over the past year
|
Dec 7
|
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event
|
Dec 6
|
CRISPR Therapeutics AG (CRSP) Up 20.5% Since Last Earnings Report: Can It Continue?
|
Dec 5
|
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
|
Dec 4
|
3 Dirt Cheap Stocks You'll Regret Not Buying Before the New Year
|
Nov 30
|
Moderna Stock Looks Sick; Here's How To Take Advantage With Options
|
Nov 30
|
‘Nobody wants to speak about COVID’: Less than 3% of eligible Americans got a booster shot in September — does that mean trouble for these 3 big vaccine stocks?
|
Nov 30
|
Moderna, Inc.'s (NASDAQ:MRNA) Intrinsic Value Is Potentially 92% Above Its Share Price
|
Nov 29
|
Airbnb downgraded, Moderna initiated: Wall Street's top analyst calls
|
Nov 28
|
AWS expands big pharma partnerships in manufacturing, AI, and R&D
|
Nov 28
|
YieldMax Launches Option Income Strategy ETF on C3.ai
|
Nov 28
|
Moderna begins work on China mRNA manufacturing site
|
Nov 27
|
11 Best Upside Stocks To Buy Right Now
|
Sep 30
|
Moderna's Shares Could Take Off if These 2 Things Happen
|
Sep 30
|
Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine
|
Sep 29
|
Moderna Recommends Shareholders Reject Amended “Mini-Tender” Offer by TRC Capital Investment Corporation
|
Sep 29
|
If I Could Only Buy 3 Stocks in 2023, I'd Pick These
|
Sep 29
|
Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
|